Helicobacter pylori eradication treatment reduces the severity of rosacea - 07/09/11
Abstract |
Background: A higher prevalence of Helicobacter pylori infection in rosacea patients than in healthy controls has been reported. Objective: The aim of this study was to investigate the effect of H pylori eradication therapy in patients with rosacea. Methods: Twenty-five rosacea patients and 87 age- and sex-matched healthy controls were included in this study. We detected IgG and IgA antibodies against H pylori in both groups. An upper gastrointestinal endoscopy and a rapid urease test were performed on the 13 patients with rosacea who accepted this procedure. Amoxicillin 500 mg 3 times daily, metronidazole 500 mg 3 times daily, and bismuth subcitrate 300 mg 4 times daily were administered to patients positive for H pylori . The severity of rosacea was scored before and after treatment. Results: There was no statistical difference in seropositivity in either group. In H pylori –positive rosacea patients there was a significant decrease in the severity of rosacea at the end of the treatment as compared with the initial scores. Conclusion: Our findings suggest that H pylori may be involved in rosacea and that eradication treatment may be beneficial. (J Am Acad Dermatol 1999;40:433-5.)
Le texte complet de cet article est disponible en PDF.Plan
Reprint requests: Serap Utaş, MD, Department of Dermatology, University of Erciyes School of Medicine, 38039-Kayseri, Turkey. |
|
0190-9622/99/$8.00 + 0 16/1/95664 |
Vol 40 - N° 3
P. 433-435 - mars 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?